GleamWall
中文EN

PRPO Precipio, Inc.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1043961 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.8%
TTM net income YoY8.8%
TTM EPS YoY27.2%
Revenue 3-yr CAGR27.9%
Net income 3-yr CAGR—

Margins

Gross margin44.6%
Operating margin-5.3%
Net margin-4.1%
FCF margin5.0%
EBITDA margin-1.1%

Returns

ROE-8.0%
ROA-5.3%
ROIC (approx.)-10.1%
Asset turnover1.30x

Leverage & solvency

Liabilities / assets31.5%
Debt / equity0.02x
Current ratio1.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.49x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$7.33M$7.02M$6.71M$6.70M$6.77M$5.65M$4.93M$5.45M
Cost of revenue$3.95M$3.88M$3.99M$3.57M$3.76M$3.23M$2.79M$2.80M
Gross profit$3.38M$3.14M$2.73M$3.13M$3.00M$2.43M$2.14M$2.65M
Operating income$2,000-$599,000-$1.43M$542,000-$61,000-$824,000-$859,000-$336,000
Pretax income-$8,000-$219,000-$1.44M$526,000-$79,000$74,000-$884,000-$365,000
Net income-$8,000-$219,000-$1.44M$526,000-$79,000$74,000-$884,000-$365,000
EBITDA$314,000-$308,000-$1.15M$849,000$246,000-$517,000-$535,000-$37,000
EPS (basic)—-0.12-0.81—-0.050.05-0.59—
EPS (diluted)—-0.12-0.81—-0.050.05-0.59—
Weighted avg. shares (diluted)1.79M1.79M1.78M—1.64M1.60M1.50M—
Balance sheet
Cash & equivalents$3.58M$3.08M$2.60M$2.65M$2.31M$1.13M$1.02M$1.39M
Receivables$2.05M$2.28M$1.99M$1.98M$1.96M$1.49M$976,000$799,000
Inventory$911,000$776,000$870,000$935,000$788,000$1.06M$825,000$724,000
Current assets$7.05M$6.54M$5.93M$6.04M$5.67M$4.05M$3.28M$3.45M
PP&E, net$1.13M$1.08M$735,000$729,000$771,000$756,000$771,000$719,000
Intangibles$10.21M$10.44M$10.68M$10.92M$11.16M$11.39M$11.63M$11.87M
Total assets$21.71M$21.32M$20.80M$21.32M$21.15M$18.82M$17.79M$17.00M
Current liabilities$3.98M$3.70M$3.81M$3.75M$4.45M$4.35M$4.33M$4.27M
Short-term debt$114,000$73,000$30,000$30,000$30,000$29,000$147,000$297,000
Long-term debt$233,000$252,000$40,000$47,000$55,000$62,000$70,000$77,000
Total debt$347,000$325,000$70,000$77,000$85,000$91,000$217,000$374,000
Total liabilities$6.85M$6.56M$6.64M$6.76M$7.40M$6.53M$6.09M$4.90M
Shareholders' equity$14.87M$14.76M$14.17M$14.56M$13.75M$12.29M$11.70M$12.09M
Net debt-$3.23M-$2.75M-$2.53M-$2.57M-$2.22M-$1.04M-$800,000-$1.01M
Shares outstanding1.79M1.79M1.78M1.78M1.75M1.52M1.50M1.49M
Cash flow statement
Operating cash flow$610,000$660,000$64,000$366,000$10,000$353,000-$44,000$565,000
Capital expenditure$56,000$132,000$50,000$75,000$54,000$59,000$138,000$44,000
Free cash flow$554,000$528,000$14,000$291,000-$44,000$294,000-$182,000$521,000
Investing cash flow-$56,000-$132,000-$50,000-$75,000-$54,000-$59,000-$138,000-$44,000
Financing cash flow-$53,000-$57,000-$61,000$55,000$1.22M-$181,000-$190,000-$185,000
Depreciation & amortization$312,000$291,000$281,000$307,000$307,000$307,000$324,000$299,000
Stock-based compensation$100,000$800,000$993,000$105,000$200,000$400,000$423,000$437,000
Share buybacks$0———————

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.